HomeFileCoronary disease

Coronary disease

ACC 2023 | Subanalysis of the REVIVED-BICS Study2

This study demonstrated that coronary angioplasty does not entail any benefit in chronic stable angina over optimal...

ACC 2023 | YELLOW III Study. Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease

Dr. Kini presented the results of the YELLOW III Study where she analyzed the effect of evolocumab...

ACC 2023 | RENOVATE-COMPLEX-PCI: Intravascular Imaging-Guided vs. Angiography-Guided Complex PCI

Patients with complex coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) have worse clinical outcomes tan...

ACC 2023 | Complete Revascularization Strategies in patients with ACS and Multivessel Disease

In patients with acute coronary syndrome (ACS) and multivessel disease, complete revascularization is associated with better clinical...

Microvascular Dysfunction in Symptomatic Patients with Intermediate Coronary Lesions Prognostic impact according to different patterns

Coronary microvascular dysfunction (CMD) is emerging as an important cause of myocardial ischemia, and its role in...

Left Main Revascularization: 12 Year Registry in Canada

The current indication for severe left main lesion continues to be coronary artery bypass graft surgery (CABG)...

Coronary Physiology after Aortic Valve Intervention

Impact of Aortic Valve Intervention on Coronary Flow Reserve Myocardial flow might be compromised in patients with severe...

Rivaroxaban in Acute Coronary Syndrome

Acute coronary syndromes (ACS) involve high mortality risk, especially ST elevation ACS. Their treatment is based on...